FDA Nears Approval of Eyelash Lengthening Drug

Allergan, Inc. the maker of Lumigan, a medication we currently use to lower the intra-ocular pressure in patients with

Photo, Lumigan ophthalmic solution

Photo, Lumigan ophthalmic solution

glaucoma, is expected to receive approval to market Lumigan to patients that wish to lengthen and thicken their eyelashes.  Lumigan is a popular drug for the treatment of glaucoma.  A side affect of Lumigan is that of thickening and lengthening the eyelashes.  Patients often ask us if there is a way to make their eyelases longer and thicker.  The answer was always yes but it’s not approved for that purpose.

The “new drug” will be called Latisse (Bimatoprost Solution 0.03%) and is pending approval for the treatment of hypotrichosis of the eyelashes (reduced amount of hair).  Latisse will cause an increase in the number, thickness and darkness of the eyelashes.  Unlike Lumigan it is not intended to go directly into the eye, but rather on the eyelashes.  Allergan expects to begin marketing Latisse in 2009.

As a side note a few years ago a patient brought a product from the Jan Marini line of skin care products into the office.  The company claimed the product contained a drug that caused the eyelashes to lengthen.  Not long after that the FDA forced it off the market.  I’m glad to see an alternative is just around the corner.

The FDA approves LATISSE(TM) December 26, 2008, read about it here.

10 responses to “FDA Nears Approval of Eyelash Lengthening Drug

  1. I’ve got to say that this drop is extremely effective for growing longer, luscious lashes! It’s effect is not subtle – trust me! Since I am relegated to trophy wife now (Dr. Rich’s wife, on medical disability), I need all the help I can get! Be sure to ask Dr. Rich about any effects it can have on light colored eyes, if you are blessed with blue or green eyes.

  2. Pingback: FDA Approves Latisse for the Treatment of Hypotrichosis of the Eyelashes « The Eye Doc Blog

  3. Allergan made it official today, December 26. LATISSE(TM) should be available in first quarter 2009. See the updated blog entry announcing the FDA’s approval. Allergan also made more details available

  4. Pingback: FDA Approves Latisse for the Treatment of Hypotrichosis of the Eyelashes « The Eye Doc Blog

  5. eyelash regrowth

    Is the eyelash growth from these products permenant or do you have to keep using it to maintain the new growth?

    • Great question. You have to keep using it to maintain the eyelashes, however you can decrease the frequency to 2 to 3 times per week.

  6. Where can i get this product? I am from Singapore, do they sell it here? If i don’t have any problem with my eyes, is it save to use lumigan just to lengthen my eyelashes? Thanks..

  7. And also, is it effective for the eyebrow too? Is there any side effect? Thanks..

    • Thanks for reading our blog. Both Latisse and Lumigan are by prescription. They both have the same active ingredient, however Latisse comes with special brushes that allow you to apply it to the lid margin. I really don’t know if it is available in Singapore. I would recommend checking with your eye doctor. Repeated application of Latisse to any skin tissue is reported to cause hair growth. The most common side effect Latisse is increased pigment in the skin, however Allergan reports that the hyperpigmentation goes away when Latisse is discontinued. I hope this helps. Good luck.

  8. Thank you for the information =)